NL-OMON41975已完成不适用
A phase I double-blind, placebo-controlled, safety, tolerability, pharmacokinetic and pharmacodynamic study of ascending single doses of ANF-Rho in comparison to standard of care-Neulasta® in healthy volunteers - ANF-Rho Phase I study in HV and comparability with Neulasta
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 入组人数
- 83
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •healthy male/female subjects
- •18-55 yrs, inclusive
- •BMI: 18.0-30.0 kg/m2, inclusive
排除标准
- •Suffering from hepatitis B, hepatitis C, cancer or HIV/AIDS. In case of participation in another drug study within 90 days before the start of this study or being a blood donor within 12 weeks from the start of the study. In case of donating more than 1.5 liters of blood (for men) or 1.0 liter of blood (for women) in the 10 months prior the start of this study.
研究者
相似试验
撤回
1 期
A clinical study to investigate the safety of multiple doses of DEN-181 in rheumatoid arthritis patientsInflammatory and Immune System - Rheumatoid arthritisRheumatoid ArthritisACTRN12617001470381Dendright Pty Ltd40
终止
1 期
A clinical study to investigate the safety of DEN-181 in rheumatoid arthritis patientsInflammatory and Immune System - Rheumatoid arthritisRheumatoid ArthritisACTRN12617001482358Dendright Pty Ltd17
已完成
不适用
*A Phase I, randomized, double-blind, placebo-controlled study to evaluate the safety, tolerability, pharmacokinetics and T-cell tolerizing effect of DC-TAB in healthy volunteers, after single and multiple dosing*nervous system disease10007951Multiple sclerosisNL-OMON34913Delta Crystallon BV76
已完成
不适用
A phase I, double-blind, randomized, placebo-controlled, multicenter, Single- and multiple-ascending-dose study to determine initial safety, Tolerability, and pharmacokinetics of GDC-0134 in patients with amyotrophic Lateral sclerosisAmyotrophic lateral sclerosisneurodegenerative disease10029317NL-OMON46547Genentech, Inc.6
进行中（未招募）
1 期
A phase I, double-blind, placebo-controlled, ascending single intravenous dose, safety, tolerability, pharmacokinetic and pharmacodynamic study in healthy participants and non-cystic fibrosis bronchiectasis patients colonized with pseudomonas aeruginosa administered INFEX702ISRCTN17978477Infex Therapeutics44